Exchange: NASDAQ·Updated 07:30 PM EST

MGTX News

News
all
press releases
MeiraGTx Holdings PLC (NASDAQ:MGTX) Stock Has Consensus Price Target of $24.00 According to Brokerages
MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendatio...
MarketBeat
MeiraGTx Holdings PLC (NASDAQ:MGTX) Stock Has Consensus Price Target of $24.00 According to Brokerages
MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendatio...
MarketBeat
More News
MeiraGTx Holdings plc (MGTX) Presents at ObesityWeek 2026 Annual Meeting - Slideshow...
SeekingAlpha
MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) CEO Alexandria Forbes sold 62,000 shares of the business's stock in a transaction on Tuesday, November 17th. The shares were sold at an average price of $8.45, for a total transaction of $523,900.00. Following the transaction, the chief...
MarketBeat
MeiraGTx Holdings PLC (NASDAQ:MGTX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 EPS estimates for MeiraGTx in a research note issued to investors on Friday, November 13th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per sha...
MarketBeat
MeiraGTx (MGTX) delivered earnings and revenue surprises of -15.22% and -29.89%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of +15.15% and +9.04%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +25.00% and -17.27%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial...
PR Newswire
MeiraGTx (MGTX) delivered earnings and revenue surprises of +538.46% and +20,637.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
TScan Therapeutics (TCRX) delivered earnings and revenue surprises of +20.69% and -61.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.